Skip to content
MedsAcross

Medicine

Atomoxetine 40 mg capsule

Atomoxetine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Atomoxetine 40 mg capsule is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…

Key facts

Active ingredient (INN)
Atomoxetine
Brand
Sold under the generic name
Strength
40 mg
Dosage form
Capsule
Route
Oral
Packs
30 capsules, 1000 capsules, 500 capsules and 35 more
Manufacturers
Zydus LifesciencesIndiaDr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaGlenmark PharmaceuticalsIndiaStrides PharmaIndiaCamber PharmaceuticalsIndiaA-S Medication SolutionsBryant Ranch PrepackCreekwood PharmaceuticalsRising Pharma Holdings
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06BA09 Atomoxetine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 May 2017
Identifiers
RxCUI 349594, 349591, 349592 +4DailyMed set ID c5e9e305-8d99-4234-b531-6ade177768b7, f98c3424-1c43-43e4-8bca-2e3430f50c63, 132852a6-5bff-15dd-255c-98309dd83630 +23NDC 72162-2544, 0904-6908, 60505-2833 +23Application ANDA079021, ANDA090609, ANDA078983 +6

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 capsule in 1 bottle65862-241-30Aurobindo PharmaIndia30 May 2017
1000 capsule in 1 bottle65862-241-99Aurobindo PharmaIndia30 May 2017
30 capsule in 1 bottle31722-717-30Camber PharmaceuticalsIndia11 March 2021
500 capsule in 1 bottle55111-521-05Dr. Reddy's LaboratoriesIndia23 February 2018
30 capsule in 1 bottle55111-521-30Dr. Reddy's LaboratoriesIndia23 February 2018
100 blister pack in 1 carton / 10 capsule in 1 blister pack55111-521-78Dr. Reddy's LaboratoriesIndia23 February 2018
2000 capsule in 1 bottle68462-268-23Glenmark PharmaceuticalsIndia30 May 2017
30 capsule in 1 bottle68462-268-30Glenmark PharmaceuticalsIndia30 May 2017
30 capsule in 1 bottle, plastic64380-475-01Strides PharmaIndia1 July 2025
500 capsule in 1 bottle, plastic64380-475-02Strides PharmaIndia1 July 2025
2000 capsule in 1 bottle68382-218-02Zydus LifesciencesIndia12 June 2017
30 capsule in 1 bottle68382-218-06Zydus LifesciencesIndia12 June 2017
1000 capsule in 1 bottle68382-218-10Zydus LifesciencesIndia12 June 2017
60 capsule in 1 bottle68382-218-14Zydus LifesciencesIndia12 June 2017
90 capsule in 1 bottle68382-218-16Zydus LifesciencesIndia12 June 2017
10 blister pack in 1 carton / 10 capsule in 1 blister pack68382-218-77Zydus LifesciencesIndia12 June 2017
30 capsule in 1 bottle60505-2833-3Apotex21 May 2018
30 capsule in 1 bottle82619-118-01Creekwood Pharmaceuticals6 July 2026
500 capsule in 1 bottle82619-118-02Creekwood Pharmaceuticals6 July 2026
30 capsule in 1 bottle64980-376-03Rising Pharma Holdings30 May 2017
1000 capsule in 1 bottle64980-376-10Rising Pharma Holdings30 May 2017
30 capsule in 1 bottle0093-3545-56Teva Pharmaceuticals30 May 2017
30 capsule in 1 bottle50090-4236-0A-S Medication Solutions29 March 2019
30 capsule in 1 bottle50090-6143-0A-S Medication Solutions4 October 2022
30 capsule in 1 bottle50090-6289-0A-S Medication Solutions19 December 2022
30 capsule in 1 bottle50090-6513-0A-S Medication Solutions1 June 2023
30 capsule in 1 bottle50090-7462-0A-S Medication Solutions19 November 2024
30 capsule in 1 bottle63629-9427-1Bryant Ranch Prepack23 August 2022
30 capsule in 1 bottle71335-2162-1Bryant Ranch Prepack7 September 2022
30 capsule in 1 bottle71335-3033-1Bryant Ranch Prepack3 December 2025
30 capsule in 1 bottle72162-2544-3Bryant Ranch Prepack16 October 2025
30 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack60687-326-25American Health Packaging8 September 2017
30 capsule in 1 bottle42291-067-30AvKARE12 April 2022
30 blister pack in 1 box / 1 capsule in 1 blister pack50268-058-13AvPAK13 February 2020
30 capsule in 1 bottle51407-103-30Golden State Medical Supply7 June 2018
30 blister pack in 1 carton / 1 capsule in 1 blister pack0904-6908-04Major Pharmaceuticals23 February 2018
30 capsule in 1 bottle16714-758-01Northstar Rx1 June 2018
30 capsule in 1 bottle72603-438-01NorthStar RxLLC2 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 November 2002Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Atomoxetine 40 mg capsule.

Compare 1

Other strengths and forms of Atomoxetine

Clinical summary

Atomoxetine is a norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients 6 years of age and older, among other approved uses. It is available as capsules and oral solution. MedsAcross supplies Atomoxetine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Atomoxetine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Atomoxetine 40 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.